NO and pulmonary arterial hypertension;

Pharmacology and clinical study of ambrisentan for treatment of pulmonary arterial hypertension;

Clinic Study on Shenfu Injection to Treat Pulmonary Arterial Hypertension of Chronic Cardiopulmonary Disease;

Effects of Enalapril or Metoprolol on plasm brain natriuretice peptide in congenital heart disease combined with pulmonary artery hypertension after transcatheter closure;

Preparation and identification of animal model with hypoxia-induced pulmonary artery hypertension;

Clinical observation on the left ventricular myocardial remodel and dysfunction in children with congenital heart disease and hypoxia-induced pulmonary artery hypertension.;

Effects of fasudil on hypoxia-induced pulmonary hypertension and vascular remodeling in rats;

Role of endogenous hydrogen sulfide in pulmonary hypertension induced by lipopolysaccharide;

Treatment of patent ductus arteriosus accompanied with severe pulmonary hypertension with transcatheter occlusion;

The Association of Polymorphism of Endothelial Nitric Oxide Synthase Gene in Patients with PAH of Chronic Obstructive Pulmonary Disease;

On Correlation between Syndrome of Sinking of Pectoral Qi and PAH;

The Research of the Applying Value of PG in the Diagnosis and Therapy of PAH by PHD;

Application of unidirectional monovalved homologousaortic patch in congenital heart disease withsevere pulmonary hypertension;

Objective\ To study the effect of unidirectional flap patch on the patients with ventricular septal defect and severe pulmonary hypertension.

To investigate the mechanism of the humoral factor-leukocyte on lung injury in congenital heart disease(CHD) with severe pulmonary hypertension during perioperation, 31 consecutive cases of CHD with ventricular septal defect (No pulmonary hypertension 16 case, severe pulmonary hypertension 15 case)were studied during perioperation.